The Construction of a Functional Photoactivatable Cancer Targeting Bispecific Antibody Conjugate
- 31 July 2007
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 2 (8) , 1162-1164
- https://doi.org/10.1002/cmdc.200700078
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- How specific are therapeutic monoclonal antibodies?The Lancet, 2006
- A simple procedure for the photoregulation of chymotrypsin activityPublished by Springer Nature ,2006
- Antibody targeted drugs as cancer therapeuticsNature Reviews Drug Discovery, 2006
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- Therapeutic antibodies for human diseases at the dawn of the twenty-first centuryNature Reviews Drug Discovery, 2003
- Light activatable antibodies: Models for remotely activatable proteinsNature Medicine, 1996
- The modulation of Protein A-IgG(Fc) binding by the reversible addition of 2-nitrobenzyl groupsBiochemical Society Transactions, 1995
- Photocleavable Nitrobenzyl-Protein ConjugatesBiochemical and Biophysical Research Communications, 1994
- UICC/CRC conference on targeted cancer therapyInternational Journal of Cancer, 1993
- Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate.Proceedings of the National Academy of Sciences, 1988